Verition Fund Management LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 433 filers reported holding REPLIGEN CORP in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.

Quarter-by-quarter ownership
Verition Fund Management LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$310,865
-34.5%
1,955
-41.7%
0.00%
-33.3%
Q2 2023$474,598
+58.5%
3,355
+88.6%
0.01%
+50.0%
Q1 2023$299,512
-73.1%
1,779
-85.0%
0.00%
-69.2%
Q3 2022$1,114,113
+173.1%
11,896
+673.0%
0.01%
+333.3%
Q4 2021$408,000
-9.3%
1,539
-31.8%
0.00%
-25.0%
Q2 2021$450,000
+37.2%
2,256
+1.5%
0.00%
-42.9%
Q3 2020$328,000
+35.5%
2,222
-72.2%
0.01%
-73.1%
Q3 2016$242,0008,0000.03%
Other shareholders
REPLIGEN CORP shareholders Q3 2022
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders